Discovery Labs of Warrington said Thursday its infant respiratory drug Surfaxin is unlikely to receive Food and Drug Administration approval without further clinical trials.

A new government report shows one in three teenage girls have rolled up their sleeves for a relatively new vaccine against cervical cancer, but vaccination rates vary dramatically between states.